Literature DB >> 26488148

Transbronchial Cryobiopsies in the Evaluation of Lung Allografts: Do the Benefits Outweigh the Risks?

Anja C Roden, Ryan M Kern, Marie Christine Aubry, Sarah M Jenkins, Eunhee S Yi, John P Scott, Fabien Maldonado1,2,3.   

Abstract

CONTEXT: Transbronchial cryobiopsy technique yields larger biopsies with enhanced quality. The benefits and safety of cryobiopsies have not been thoroughly studied in lung allografts.
OBJECTIVE: To compare size, quality, reproducibility of interpretation of rejection and complications of cryobiopsies with those of conventional biopsies from lung allografts.
DESIGN: All cryobiopsies (March 2014-January 2015) of lung allografts performed at Mayo Clinic, Rochester, and medical records were reviewed. For comparison, conventional biopsies from the same patient or, if unavailable, from a random patient, were selected. Two pathologists blinded to outcome reviewed all biopsies. Specimen volume, number of alveoli, small airways, and pulmonary vessels were counted and statistically compared.
RESULTS: Fifty-four biopsies (27 cryobiopsies) from 18 patients (11 men) were reviewed. A median of 3 (range, 2-5) and 10 (range, 6-12) specimens were obtained with cryobiopsies and conventional biopsies, respectively. Cryobiopsies were larger and contained more alveoli (P < .001, both) and small airways (P = .04). Conventional biopsies showed more fresh alveolar hemorrhage (procedural) and crush artifact/atelectasis (P < .001, both). Cryobiopsies contained more pulmonary veins and venules (P < .001). There was no significant difference between the types of biopsies with respect to the reviewers' agreement on grades of rejection. Complications were more frequent in the cryobiopsy group, though the difference was not statistically significant.
CONCLUSIONS: Cryobiopsies of lung allografts are larger and have less artifact. However, complications occur and should be considered. Three cryobiopsy specimens appear sufficient for histopathologic evaluation of lung allografts.

Entities:  

Mesh:

Year:  2015        PMID: 26488148     DOI: 10.5858/arpa.2015-0294-OA

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  5 in total

Review 1.  Acute rejection.

Authors:  Mark Benzimra; Greg L Calligaro; Allan R Glanville
Journal:  J Thorac Dis       Date:  2017-12       Impact factor: 2.895

Review 2.  Chinese expert consensus on the standardized procedure and technique of transbronchial cryobiopsy.

Authors:  Shuliang Guo; Qiang Li; Jinyue Jiang; Fengming Luo; Yishi Li; Faguang Jin; Xinzhu Liu; Hongwu Wang; Ping Chen; Chong Bai; Haiyun Dai; Haidong Huang; Xianwei Ye; Xianghua Yi; Jie Zhang; Changhui Wang; Mingyao Ke; Jiayuan Sun; Jing Feng; Hongmei Zhou; Youru Wu; Zhen Wang; Yun Ma; Jing Li; Liping Lv; Baosong Xie; Wolfgang Hohenforst-Schmidt; Weimin Ding; Xiaoping Wang; Junyong Yang; Qingshan Cai; Peng Sun; Zhuang Luo; Mohan Giri
Journal:  J Thorac Dis       Date:  2019-12       Impact factor: 2.895

3.  Bronchoscopic Cryobiopsy and Forceps Biopsy for the Diagnostic Evaluation of Diffuse Parenchymal Lung Disease in Clinical Practice.

Authors:  Matthew Koslow; Eric S Edell; David E Midthun; John J Mullon; Ryan M Kern; Darlene R Nelson; Kenneth K Sakata; Teng Moua; Anja C Roden; Eunhee S Yi; Janani S Reisenauer; Paul A Decker; Jay H Ryu
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2020-10-06

Review 4.  From electrocautery, balloon dilatation, neodymium-doped:yttrium-aluminum-garnet (Nd:YAG) laser to argon plasma coagulation and cryotherapy.

Authors:  Ashutosh Sachdeva; Edward M Pickering; Hans J Lee
Journal:  J Thorac Dis       Date:  2015-12       Impact factor: 2.895

5.  Transbronchial Cryobiopsy Compared to Forceps Biopsy for Diagnosis of Acute Cellular Rejection in Lung Transplants: Analysis of 63 Consecutive Procedures.

Authors:  Carolin Steinack; Ariana Gaspert; Fiorenza Gautschi; René Hage; Bart Vrugt; Alex Soltermann; Macé Matthew Schuurmans; Daniel Franzen
Journal:  Life (Basel)       Date:  2022-06-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.